Mutations in rhodopsin (RHO) are a common cause of retinal dystrophy and can be transmitted by dominant or recessive inheritance. Clinical symptoms caused by dominant and recessive mutations in patients and animal models are very similar but the molecular mechanisms leading to retinal degeneration may differ. We characterized three murine models of retina degeneration caused by either Rho loss of function or expression of the P23H dominant mutation in Rho. Rho loss of function is characterized by activation of calpains and apoptosis-inducing factor (Aif) in dying photoreceptors. Retinas bearing the P23H dominant mutations activate both the calpain-Aif cell death pathway and ER-stress responses that together contribute to photoreceptor cell demise. In vivo treatment with the calpastatin peptide, a calpain inhibitor, was strongly neuroprotective in mice lacking Rho while photoreceptor survival in retinas expressing the P23H dominant mutation was more affected by treatment with salubrinal, an inhibitor of the ER-stress pathway. The further reduction of photoreceptor cell demise by cotreatment with calpastatin and salubrinal suggests co-activation of the calpain and ER-stress death pathways in mice bearing dominant mutations in the Rho gene.
Introduction autosomal recessive Retinitis Pigmentosa (arRP) and congenital night blindness (CNB) (3, 4) . The molecular mechanisms underlying cell death caused by either dominant or recessive mutations in RHO are still not well characterized.
Rhodopsin (RHO) is a G-protein coupled receptor localized to rod outer segments where the phototransduction cascade is initiated. RHO is the most abundant protein produced by rod cells accounting for 30% of their total protein content and is particularly enriched, up to 90%, in the rod outer segments (5) (6) (7) . Data regarding the pathogenic mechanism(s) of mutant RHO are still controversial. Accumulation of mutant RHO in different subcellular compartments, including the endoplasmic reticulum (ER), may trigger the unfolded protein response (UPR) with cytoprotective outputs that reduce protein synthesis and up-regulate chaperones to cope with stress (8) . Excessive mutant RHO accumulation can then lead to ER-stress responses that culminate with cell death (9) . ER-stress and other mechanisms involving the ER-associated degradation (ERAD) pathway and autophagy have been linked to RHO mutation and may all contribute to retinal degeneration (10, 11) . Saliba and colleagues reported that exposure of p.Pro23His (P23H) mutant RHO, the most common mutation in the US (12) , to 9-cis-retinal in transfected cells increased plasma membrane localization of the mutant protein but did not decrease the formation of aggresomes or their detrimental effects (13) . Murine models to study effects caused by mutant RHO and specifically the P23H mutation are available as transgenic mice and rats (14, 15) that suffer a very severe form of retinal degeneration. More recently, two knock-in mouse models were generated for the P23H mutation and they show a much slower progression of the disease (16, 17) .
Quality control during protein synthesis imposed by the ER activates ER resident sensors involved in the UPR to allow only properly folded proteins to leave the organelle. Expression of mutant proteins may affect cellular ability to cope with UPR causing the cell to activate ER-stress and succumb to apoptosis. The transducers of the UPR/ER-stress responses are ER resident proteins: the inositol-requiring enzyme 1 (Ire1), the activating transcription factor-6 (Atf6) and the protein kinase R-like ER protein kinase (Perk). Ire1 is a ribonuclease that, when activated, splices the mRNA encoding X-box transcription factor 1 (Xbp1), leading to a frame shift and production of sXbp1, a transcription factor regulating expression of chaperones. The Perk pathway is characterized by phosphorylation of Perk and eukaryotic initiation factor-2a (eIF2a) resulting in reduction of protein synthesis and up-regulation of Atf4 that regulates expression of several cell death related genes (18) .
We previously showed that calpain activation as well as nuclear translocation of Aif (Apoptosis-inducing factor) plays fundamental roles in photoreceptor cell death in the retinal degeneration 1 (rd1) mouse model (19, 20) . Aif is a mitochondrial protein that can be cleaved by calpains, leaves the mitochondrion through a pore formed by Bax and recruits Cyclophilin A for chromatin fragmentation (21, 22) . Aif, as well as ERstress, were reported to be activated in P23H transgenic rodents (23) (24) (25) .
In this study, we characterized the interrelationship of these calpain-mediated and ER stress-mediated cell death pathways in Rhodopsin mutant mice. Specifically, we compared the Rho knock-out mouse, a model for arRP, with two lines of mice expressing P23H mutant Rho, models for adRP. We isolated expression of the P23H mutation from wild-type Rho in one of the two models to uncover molecular cytotoxic mechanisms activated by the dominant mutation. Co-expression of wild-type Rho, in fact, alleviates the phenotype and may hinder the characterization of molecular pathways (9) . We characterized the different contributions of the two pathways by in vivo treatments with drugs targeting either calpains or ER-stress. We demonstrated that Rho loss of function did not activate ERstress pathways but induced cell death through activation of calpains. In photoreceptors bearing the P23H dominant mutation, both pathways were activated but ER stress appeared to play a critical role. Finally, we showed the protective effects in more than one murine model by targeting both pathways with a drug combination.
Results

Activation of Calpains and Aif in dying rod cells bearing mutations in the Rho gene
To study the molecular effects of a dominant compared to a recessive mutation in the Rho gene, we evaluated cell death pathways activated in rod photoreceptors. We analyzed the transgenic mouse expressing human P23H RHO (P23H Tg ) (14) , the knock-in P23H mouse (17) bred to eliminate the wild-type Rho allele (Rho
P23H/-
) and compared them to the homozygous Rho knock-out mouse (Rho -/-) (26) . We chose to study the P23H mutation in the absence of wild-type Rho in one of the murine models to uncover molecular mechanisms activated by the mutation and limit protecting effects from the wild-type protein (9) . The peaks of cell death in the retinas of these chosen murine models were post-natal day 9 (PN9) for P23H Tg , PN16 for Rho P23H/-and PN45 for Rho -/-(as reported in (27) (9, 17, 28) . Retinas expressing only P23H mutant Rho had more forms at higher molecular weights that probably represent aggregates/multimers, as reported in vitro and in vivo for dominant RHO mutations (9, (29) (30) (31) . Moreover, immunofluorescence analyses showed accumulation of P23H mutant Rho around the nuclei of photoreceptors suggesting that it aggregates inside the cells (Supplementary Material, Fig. S1C ). We previously characterized the molecular pathways of cell death in the rd1 mouse model of RP and showed that calpain and Aif play key roles in photoreceptor demise (19, 27) . Activation of calpains was reported in several rodent models of RP and we reported calpain activation in P23H
Tg and Rho -/-degenerating retinas (32, 33) . In this study, we confirmed activation of calpains in all the chosen mouse models by assessing the cleavage of aII-spectrin, a substrate for calpains (34) as well as using the previously published in situ calpain activity assay (19, 20, 27) . Protein analysis confirmed an increase of the 145 kDa fragment of aII-spectrin consistent with cleavage by calpains (Fig. 1A, (Fig. 1B) .
We then evaluated Aif activation and nuclear translocation by immunofluorescence imaging and immunoblotting of nuclear extracts derived from wild-type and Rho mutant retinas. Aif translocation into the photoreceptor nuclei of these three murine models was high at their peaks of cell death (Fig. 1C , arrows and Supplementary Material, Fig. S1 E-G). We counted cells with nuclear localization of Aif that were co-labeled by TUNEL and found that about 50% of both P23H
Tg and Rho P23H/-dying cells showed Aif inside their nuclei, similar to cells activating calpains (Fig. 1D) . A stronger correlation of Aif activation with TUNEL was observed in Rho -/-retinas (Fig. 1D) . Aif translocation into the nuclei of dying photoreceptor cells was confirmed by immunoblotting that compared nuclear extracts from wild-type and mutant retinas (Fig. 1E) . Altogether these data demonstrate that calpains are activated and Aif translocates into the nuclei of photoreceptor cells in mouse models of RP caused by Rho mutations. Activation of calpains can be induced by increase of intracellular calcium as reported in the rd1 mutant retina (19, 34) . Using a fluorescent dye we compared calcium levels in wild-type and mutant photoreceptors and found more photoreceptor cells with high levels of calcium in retinas bearing mutations in Rho (Supplementary Material, Fig. S2 ).
Calpains activate Aif in Rho mutant retinas
To address whether Aif is activated by calpains in Rho mutant retinas we injected mice intravitreally with the calpain-specific inhibitor calpastatin peptide either at PN9 (P23H injection protocol was similar to the previously published method (20) . Effectiveness of calpastatin peptide treatment was confirmed by the reduction of the 145 kDa fragment of aII-spectrin ( Fig. 2A, arrow) . We also observed a significant reduction of the number of photoreceptors activating calpains, based on the in situ calpain activity assay (Fig. 2B ). Sixteen hours after calpastatin peptide injection, we detected a strong reduction of cell death in Rho -/-retinas as defined by the loss of TUNEL labeled cells as well as a decrease of cells showing activation of Aif ( Fig. 2C-E ). Activated Aif protein inside the nuclei was undetectable in Rho -/-retinas after treatment with calpastatin peptide (Fig. 2C ). Calpain inhibition was thus very effective in reducing cell demise in retinas bearing recessive mutations in the Rho gene. Calpastatin peptide, significantly but at a lower level, reduced cell death and Aif nuclear translocation in retinas expressing the P23H mutation ( Fig. 2C-E ). This limited effect of calpain inhibition implies that calpains and Aif are not the only cell death factors triggered in photoreceptors cells expressing dominant mutations in Rho.
Activation of ER-stress in P23H Rho mutant rods
Activation of ER-stress was previously shown in rodent P23H mutant retinas (23, 35) . We wished to define the timing of activation of Ire1 and Perk ER-stress sensors in our murine models expressing mutant Rho and correlate this to cell death as defined by TUNEL staining. No activation of ER stress sensors was detectable in Rho -/-retinas at any time point during degeneration (data not shown), thus the homozygous recessive model was not further analyzed in this study. Activation of Ire1, defined by detection of phosphorylated Ire1, was observed in P23H Tg retinas with a marked decrease at PN10 (Fig. 3A) . To confirm that Ire1 phosphorylation activated the pathway, we evaluated the alternative splicing of Xbp1 with specific primers for spliced Xbp1 (sXbp1). Splicing of Xbp1 (sXbp1) detectable at PN8 and PN9 but not at PN10 confirmed that activation of the Ire1 pathway declined with progression of retinal degeneration (Fig. 3B) . Using antibodies for phosphorylated Ire1, we confirmed that phosphorylation of the ER-stress sensor Ire1 resided in photoreceptor cells and not in other retinal cells (Fig. 3C , arrow). Similar results were obtained by analyzing Ire1 phosphorylation and Xbp1 splicing in Rho P23H/-retinas ( Fig. 4A-C (Fig. 5O) . Bip/Grp79 is a member of the Hsp70 family of chaperones that regulate ER stress signaling by binding to Ire1 and Perk. Over-expression of Bip/Grp79 in P23H mutant retinas was previously reported to be protective and to reduce retinal degeneration (23) . We thus analyzed the Bip/Grp79 in retinas before and after treatments and found that salubrinal, but not calpastatin, increased Bip/Grp79 protein levels (Fig. 5K-L Fig. S3K-L) .
Targeting Calpains and ER-stress has additive protective effects in rod photoreceptors expressing P23H mutant Rho Data described so far could not define if the different treatments were blocking the same cell death pathway at different levels or were interfering with different pathways activated in parallel.
To address this question, we co-treated mice with salubrinal and calpastatin peptide in vivo. The effects of salubrinal on the ER stress sensors were maintained also in the presence of calpastatin peptide, as demonstrated by increase in phosphorylation of Eif2a and of Ire1 (Fig. 5A-H and Supplementary Material, Fig. S3A-H) . The combined treatment with salubrinal and calpastatin peptide also increased the levels of Bip/Gpr79 protein in both murine models expressing the P23H mutant Rho (Fig.  5K-L Fig. S4A, C, D) . The short time frame between injections and analyses helps biochemical studies but does not allow assessment of phenotype rescue with an increased number of photoreceptor cells or redistribution of the RHO protein (Supplementary Material, Fig. S4 ).
Discussion
In this study, we report a molecular characterization of cell death pathways in one model of recessive RP caused by Rho loss of function and two models of dominant RP caused by point mutations in Rho. The most interesting finding is a common mechanism of cell death, the calpain-mediated pathway, associated with both recessive and dominant Rho mutations. Interestingly, activation of calpains appears to be a general mechanism initiated by photoreceptors during retinal degeneration since calpains have been found activated in several animal models of RP (19, 20, 24, 25, 27, 33, 34, (37) (38) (39) (40) (41) . The key role of calpains in retinal degeneration was also demonstrated after light damage on a canine model of RP bearing a mutation in the RHO gene (42) . We also show co-activation of calpains and Aif suggesting that calpains may activate Aif in response to mutations of Rho similar to what we previously reported in the rd1 mutant retinas (19) . The reduction of Aif activation in retinas treated with calpastatin peptide, a calpain inhibitor, confirms this hypothesis. Calpastatin peptide is able to completely abolish Aif nuclear translocation as well as cell death in the Rho -/-retina but not in retinas expressing the P23H dominant mutation. This indicates that the main cell death pathway activated in RP linked to recessive mutation in Rho is mediated by calpains. We cannot exclude involvement of other mechanisms of cell death but prolonged exposure to calpain inhibitors will be required to uncover other players.
Activation of Aif appears to be mediated by calpains in all mutant retinas studied here, however expression of the dominant mutation may trigger other mechanisms that affect activation of Aif. In fact, in both animal models bearing the P23H mutation salubrinal treatment caused a significant reduction of activated Aif in the retina but not of activated calpains. The different effect on Aif and on calpains can be explained by the fact that Aif can be activated by several proteases and among those caspases (43, 44) . Activation of caspases in retinas with dominant mutations in Rho have been previously reported (23, 24, 33, 42, (45) (46) (47) and is also suggested by our analyses of cleavage of the cytoskeletal protein aII-spectrin that revealed lower molecular weight fragments in P23H mutant retinas, not observed in the retina with Rho loss of function.
The expression of a dominant mutation in Rho activates additional pathways involving ER-stress. Mutations in integral membrane proteins affecting folding cause ER retention and are linked to diseases, as also shown for Rho (48, 49) . Correlation of the ER-stress Perk pathway with intracellular Ca 2þ variations and with calpains was previously described in retina and brain neurons but not well characterized (50) (51) (52) (53) (54) . By treatment with drugs targeting either calpains or ER-stress, we determined that these are parallel pathways. In fact, treatment with calpastatin did not significantly affect phosphorylation of ER-stress sensors. Similarly, treatment with salubrinal did not only reduce the number of cells activating calpains but also nearly increased calpain activity even in the presence of calpastatin. Salubrinal was reported to only moderately reduce calpain activity when a cancer cell line was pretreated with salubrinal before activation of calpains and to increase cytosolic Ca 2þ in EBV-transformed B cells (55, 56) . If indeed salubrinal increases cytosolic Ca 2þ in photoreceptors as well, this may activate several calpains and not only calpain 1 and 2. Calpastatin specifically blocks calpain 1 and 2 that we previously demonstrated to be linked to photoreceptor cell death (27) . Interfering with the two pathways in co-treatment experiments showed a significant benefit when compared to single treatments confirming that calpains and ERstress are independently activated. Our study thus highlights the importance of combined treatments of dominant RP caused by mutations in the RHO gene. Neuroprotective effects with salubrinal are consistent with the beneficial effects observed in photoreceptors from a patient bearing a dominant RHO mutation (E181K) (57) . Interestingly, in our studies salubrinal not only increased phosphorylated Eif2a but also maintained activation of Ire1. Sustained expression of activated Ire1 was previously shown to have protective effects in Drosophila on photoreceptors expressing mutant Rho (58) . Salubrinal was also previously reported to protect cells from the deleterious effect of ER-stress in a Drosophila model of retinal degeneration (59).
Activation of ER-stress is consistent with the observation of high molecular weight Rho protein in retinal extracts from mice expressing the dominant mutation. We also observed a different distribution of the protein in the photoreceptor cells. These data are partially discordant with a study of the knock-in mouse expressing two P23H mutant alleles (28) . The apparent discrepancy may be due to the different genotypes of the mice used in the two studies. In fact, in this study, we analyzed mice bearing a single mutant allele in the absence of the wild-type allele while the published study analyzed mice with two P23H mutant alleles. A second explanation may reside with the methods used here for epitope retrieval in immunofluorescence experiments and for protein extraction in immunoblotting. In fact, different detergents were reported to affect the Rho pattern during immunoblotting (60) .
Recessive mutations are rare in the RHO gene and the only confirmed null mutation is the E249X mutation identified in one patient (4) . The loss of function effects of the second mutation, E150K, found in homozygosity in patients is still controversial because molecular and functional studies in the recently generated knock-in mouse identify this mutation as a slowly progressing adRP (61) .
In summary, our study demonstrates that dominant and recessive mutations in the Rho gene trigger different responses in photoreceptor cells. While clinical symptoms are similar in patients with adRP and arRP, RP caused by the P23H mutation is not due to haploinsufficiency, and therapeutic strategies will need to account for the different molecular events triggered by different mutations. Our study only assessed the effects of calpastatin peptide and salubrinal on the retina after 16 h of exposure analyzing the number of TUNEL þ cells and activation of the pathways, these experiments are therefore not appropriate to evaluate preservation of the number and morphology of rod and cone photoreceptors. Long-term effects of these drugs in the eye as well as neuroprotective activities need to be evaluated for their therapeutic use in retinal degeneration. Treatments in vivo with salubrinal or continuous expression of calpastatin in the forebrain of transgenic mice did not show adverse effects, but long-term exposure in the eye was not assessed (62) (63) (64) (65) (66) . The identification of the two cell death pathways paves the way for specific pharmacological screenings to identify new, safe and effective drugs for the treatment of this blinding disease.
Materials and Methods
Animal care
All procedures on mice were conducted at CSSI (Centro Servizi Stabulario Interdipartimentale) and approved by the Ethical Committee of University of Modena and Reggio Emilia (Prot. N. (14) were kindly provided by M. Humphries and T. Dryja and bred on a C57BL/6J genetic background, C57BL/6J wild-type mice were purchased from Envigo Italy (Udine, IT). We chose to maintain the endogenous murine Rho in this model because, in the absence of endogenous Rho, retinal degeneration proceeds rapidly affecting our analyses. Rho -/-mice in a 129/sv background (26) were kindly provided by M. Humphries. The P23H knock-in mice in a C57BL/6J background (17) were mated with the Rho knockout mice to obtain mice with one Rho null allele and one P23H mutant Rho allele (Rho
P23H/-
). Mice were maintained in a 12 h light/dark cycle and had free access to food and water.
In vivo treatments
For intravitreal administration, mice at the age of 9 days after birth (PN9) or PN15 or PN44 were anesthetized with an intraperitoneal injection of 250 mg/kg body weight of avertin (1.25% (w/v) 2,2,2-tribromoethanol and 2.5% (v/v) 2-methyl-2-butanol; Sigma, Milan, IT). Subsequently, the eyelid was opened and a 34GA needle was inserted adjacent to the limbal border of the cornea. A 0.5 ll of calpastatin peptide (200 lM solution, with an expected final concentration in the eye of 20 lM; Calbiochem, Milan, IT) were delivered intravitreously and the control eyes received vehicle only (PBS). Salubrinal was injected twice per day intraperitoneally starting at the age of PN7 (50 ll of a 1:50 dilution in 0.9% NaCl of a 5 mg/ml stock solution in DMSO; Calbiochem). Control mice received the same volume of vehicle (2% DMSO in 0.9% NaCl).
Calpain activity assay
Cryosections from unfixed retinas were incubated for 15 min in calpain reaction buffer (CRB: 25 mM HEPES-KOH pH 7.2, 65 mM KCl, 2 mM MgCl 2 , 1.5 mM CaCl 2 , 2 mM DTT) and then exposed for 1 h at 37 C to the fluorescent calpain substrate CMAC, t-BOC-Leu-Met (A6520, Life Technologies, Monza, IT) at a final concentration of 2 mM as in (20 
RT-PCR
Total RNA was extracted from murine retinas with Trizol (Life Technologies) and cDNA was synthesized using the Transcriptor High Fidelity cDNA Synthesis Kit (Roche). PCR analysis of the spliced form of Xbp1 was performed with primers specifically recognizing the spliced variant (sXbp1-f: GGTCTGCTGAGTCCGCAGCAGG and sXbp1-r: CAGGCCTATGC TATCCTCTAGGC) with the following protocol: 10 min 
Retinal protein extracts and Western blotting analysis
Retinas were dissected in PBS. Total cell extracts were prepared by homogenizing retinas in 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% CHAPS, 0.2 mM Na 3 PO 4 , 1 mM Na 3 VO 4 , protease inhibitor cocktail (Sigma) and centrifugation at 17 000g for 10 min. For nuclei-enriched lysate preparation, retinas were transferred into a 2 ml Dounce homogenizer with 200 ll of cold homogenizing buffer (20 mM HEPES-KOH pH 7.5, 250 mM sucrose, 10 mM KCl, 1.5 mM MgCl 2 , 2 mM EDTA, 1 mM DTT, 0.2 mM Na 3 PO 4 , 1 mM Na 3 VO 4 , protease inhibitor cocktail from Sigma) and placed on ice for 30 min. The tissue was disrupted with 40 strokes and centrifuged at 900g for 5 min at 4 C to isolate the nuclear fraction. The pellet was washed twice in cold homogenizing buffer and resuspended in lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.1% SDS, 1 mM EDTA, 0.2 mM Na 3 PO 4 , 1 mM Na 3 VO 4 , protease inhibitor cocktail from Sigma). The purity of enriched lysates was checked by western blotting with a nuclear marker (anti-Histone H3 1:3000; Bethyl Laboratories, Bologna, IT) and a cytosol marker (anti-pan-actin, 1:3000, Millipore). Equivalent amounts of protein extracts (3 lg for total extracts, 20 lg for nuclear extracts and 80 lg for analyses of aIIspectrin) were resolved using SDS-PAGE and immunoblottings were performed following standard procedures. The antibodies used for immunoblotting were: anti-Aif (1:1000; Oncogene), anti-aII-spectrin (anti-fodrin; 1:2000, Enzo Life, Roma, IT), antiBip (1:1000, Santa Cruz Biotechnology), anti-Eif2a (1:1000, Cell Signaling), anti-Histone H3 (1:3000; Bethyl Laboratories), anti-phosphorylated-Ire1 (1:2000, Novus Biologicals), antiphosphorylated-Perk (1:1000, Cell Signaling), anti-phosphorylated-Eif2a (1:1000, Cell Signaling), anti-Perk (1:1000, Santa Cruz Biotechnology), anti-pan-actin (1:3000, Millipore) and antirecoverin (1:1000, Millipore). Quantification was performed by densitometry analysis of scanned images with ImageJ software, corrected for background and plotted as protein/normalizing protein. Data are presented as means 6 SD of 3 blots with proteins derived as biological replicates from three animals.
Statistical analysis
Cell counts and densitometry analyses are shown as means 6 SD. Paired Student's t-test analysis was performed to compare data derived from at least three different wild-type or mock treated mutant retinas to at least three different mutants or drug treated retinas, respectively.
Supplementary Material
Supplementary Material is available at HMG online.
